Pharma & BioPharma Market

Vinit Saxena is the founder and CEO of Sepragen Corporation. He has developed and commercialized innovative technologies for fast and efficient Bio-purification and Cell Culture that are routinely used by leading biotechs in the commercial manufacture of over 24 FDA approved drugs. Also Co-developed the Sepralac process for isolating whey proteins and developed other pioneering technologies used for isolating high nutritional ingredients. Authored 12 patents. Sepragen Corporation is a proven technology leader with a recognizable and growing presence in its chosen fields.